↓ Skip to main content

Infectious Complications in Biologic and Targeted Therapies

Overview of attention for book
Infectious Complications in Biologic and Targeted Therapies
Springer International Publishing

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Overview of the Risk of Infection Associated with Biologic and Target Therapies
  3. Altmetric Badge
    Chapter 2 Timeline and Infectious Disease Evaluation of Candidates to New Therapies
  4. Altmetric Badge
    Chapter 3 Safety and Efficacy of Vaccines in Patients on Targeted and Biologic Therapies
  5. Altmetric Badge
    Chapter 4 Travel and Risk of Infections
  6. Altmetric Badge
    Chapter 5 Anti-tumor Necrosis Factor-Alpha Agents
  7. Altmetric Badge
    Chapter 6 CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4
  8. Altmetric Badge
    Chapter 7 CD19, CD20 and CD52
  9. Altmetric Badge
    Chapter 8 Cell-Surface Receptors: EGFR- and VEGFR-Targeted Agents
  10. Altmetric Badge
    Chapter 9 Interleukin-1 Targeted Agents
  11. Altmetric Badge
    Chapter 10 Interleukin-6 Targeted Agents
  12. Altmetric Badge
    Chapter 11 Interleukin-12 and -23 Targeted Agents
  13. Altmetric Badge
    Chapter 12 Sphingosine-1 Phosphate Receptor Modulators
  14. Altmetric Badge
    Chapter 13 Immune Checkpoint Inhibitors
  15. Altmetric Badge
    Chapter 14 α4-Integrin (and Other Leukocyte Integrin)-Targeting Agents
  16. Altmetric Badge
    Chapter 15 Tyrosine-Kinase Inhibitors
  17. Altmetric Badge
    Chapter 16 Bcl-2, JAK and mTOR Inhibitors
  18. Altmetric Badge
    Chapter 17 Infection Associated with the Use of CAR T Cells
  19. Altmetric Badge
    Chapter 18 Pulmonary Infiltrates
  20. Altmetric Badge
    Chapter 19 Tuberculosis
  21. Altmetric Badge
    Chapter 20 Cytomegalovirus and Other Herpesviruses
  22. Altmetric Badge
    Chapter 21 Invasive Fungal Disease
  23. Altmetric Badge
    Chapter 22 Progressive Multifocal Leukoencephalopathy
  24. Altmetric Badge
    Chapter 23 Hepatitis Viruses
  25. Altmetric Badge
    Chapter 24 Immune-Targeted Therapies for COVID-19
Attention for Chapter 11: Interleukin-12 and -23 Targeted Agents
Altmetric Badge

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Interleukin-12 and -23 Targeted Agents
Chapter number 11
Book title
Infectious Complications in Biologic and Targeted Therapies
Published by
Springer, Cham, January 2022
DOI 10.1007/978-3-031-11363-5_11
Book ISBNs
978-3-03-111362-8, 978-3-03-111363-5
Authors

Fernández-Ruiz, Mario

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Other 1 100%
Readers by discipline Count As %
Medicine and Dentistry 1 100%